Cite
HARVARD Citation
Leon, L. et al. (n.d.). AB0451 Incidence of opportunistic infections during rituximab, abatacept or tocilizumab treatments for rheumatoid arthritis in clinical practice. Annals of the rheumatic diseases. pp. 1387-1388. [Online].